A potential novel treatment for cirrhosis-related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease.
肝硬化相關腹水的潛在新治療:Empagliflozin在晚期慢性肝病中是安全且可耐受的。
Br J Clin Pharmacol 2024-06-17
Emerging Role of Low-dose Loop Diuretics in the Management of Heart Failure Patients to Maintain Euvolemia.
低劑量環利尿劑在心衰竭患者維持正常血容量管理中的新興角色。
J Assoc Physicians India 2024-09-18